MLC.IR Malin Corporation plc

Healthcare Pharmaceuticals Irish Exchange
5.95 EUR
Close of Oct 27, 2026
5.95 9.30
Market cap
EUR 25.7M
P/E
-
P/B
0.13x
ROE
0.0%
Dividend yield
-
Fundamental score
1.1/5

Ratios use the latest price and the fiscal year ending Dec 2024.

Is MLC.IR undervalued?

Graham number

The Graham number of Malin Corporation plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Malin Corporation plc fundamental analysis

5 of 21 checks passed

ROE 0/2

Low return on equity (0.0%), below 10%.

ROA 0/1

Return on assets (0.0%) is below the industry median (3.8%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Earnings growth cannot be compared with the industry.

Revenue Growth 0/2

Revenue did not grow over the past 3 years or is not reported.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Cash Runway 2/2

Cash covers 47.8 years of the current cash burn.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (0.1x) is below the industry median (1.5x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Malin Corporation plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Malin Corporation plc

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.

Full company profile